SpectraScience to Hold Business Update Conference Call on March 27, 2012
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 03/14/12 -- SpectraScience, Inc. (OTCQB: SCIE) (PINKSHEETS: SCIE), a San Diego-based medical device company, today announced that it will hold a conference call on Tuesday, March 27, 2012 at Noon Eastern (9:00 a.m. Pacific) to provide an update on its business and conduct a question and answer session with investors.
Individuals interested in listening to the conference call may do so by dialing 877-407-0782, or for international callers 201-689-8567. The call is also being webcast, and can be accessed at .
A telephone replay will be available through May 27, 2012 by dialing 877-660-6853, or for international callers 201-612-7415, and entering the Account # 286, and the Conference ID # 390595. The webcast will be available on the Company's website for 90 days following the completion of the call.
SpectraScience is a San Diego-based medical device company that designs, develops, manufactures and markets light-based diagnostic systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With CE Mark approval for sale in the European Union, the WavSTAT4 System is the first commercially available product that incorporates this innovative technology for clinical use.
Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer
(858) 405-9933
Investor Relations
LHA
Don Markley
(310) 691-7100
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.03.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 124729
Anzahl Zeichen: 0
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 138 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SpectraScience to Hold Business Update Conference Call on March 27, 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
SpectraScience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
